21.2 Percutaneous Image-Guided Needle Biopsy
Key Takeaways
FNA supplies cells or fluid for cytology and selected ancillary tests. Core biopsy preserves architectural relationships in the sampled tissue.
For side-notch core devices, verify the actual stylet and cutting stroke as well as the coaxial component sizes and working lengths.
For lung biopsy, plan a safe trajectory and monitor for pneumothorax, hemoptysis and rare systemic gas embolism. Use biopsy-side-down rollover for selected stable patients when ordered and feasible.
Transjugular liver sampling is an alternative when ascites or bleeding risk makes the percutaneous route unsuitable. Monitor for complications with either route.
Plan sample allocation before the procedure. Keep tissue for culture or live-cell flow cytometry separate from the routine fixed specimen.
21.2 Percutaneous Image-Guided Needle Biopsy
Clinical Core: Prepare the method, imaging, device combination and lab containers for the clinical question. A fine-needle aspirate supplies cells or fluid, while a core samples a piece of tissue with architectural relationships. For either approach, confirm the planned trajectory, monitor for complications and coordinate allocation with the receiving laboratory.
Fine needle aspiration and core biopsy
| Method | How it samples | How the result can be used |
|---|---|---|
| Fine needle aspiration (FNA) | A small needle collects cells, small clusters or fluid through suction or, for some targets, capillary sampling without suction. | Prepare smears or a cell block as ordered. Ancillary testing can be possible on suitable material. The aspirate usually provides limited information about tissue architecture. |
| Core needle biopsy (CNB) | A cutting device captures a portion of tissue. The provider chooses gauge, specimen length and number of samples for the target and purpose. | Tissue architecture helps with diagnosis, typing and grading, and may support immunohistochemistry or molecular testing if enough viable material is obtained. A core samples only part of the lesion. |
For suspected primary retroperitoneal sarcoma, the Transatlantic Australasian working group recommends image-guided coaxial core biopsy, often with 14–18 gauge needles. The radiologist selects viable representative tissue and evaluates intervening organs and vessels. Other conditions can call for a different size or approach. For high suspicion of lymphoma, the ASCP/CAP guideline favors excisional or core tissue. FNA cytomorphology alone is insufficient for definitive diagnosis, although aspirate with appropriate ancillary studies can answer selected questions. Confirm whether fresh material for flow is requested as well as tissue for histology.
Cutting devices and coaxial access
In a side-notch core device, an inner stylet exposes a specimen notch in the target. The outer cutting cannula travels over the notch to separate and retain the sample. Automatic systems can drive both actions in sequence. In some semi-automatic systems, the operator advances the stylet first and then triggers the cutting cannula. Read the actual device instructions because the trigger, throw and notch length vary. The tip and entire throw path must be within the planned safe sampling region.
A coaxial system leaves an outer introducer in place so multiple samples can be taken without re-establishing skin access for every pass. The needle, introducer and depth settings must be compatible in size and length. A common example is an 18-gauge needle with its specified 17-gauge introducer. Consult the listed configuration instead of assuming this pairing from gauge alone. The number of passes depends on sample adequacy and patient risk. A tract seal such as an autologous blood patch or a hydrogel plug is an option for selected lung biopsies. A randomized comparison found blood patch noninferior to hydrogel plug for the specified pneumothorax endpoint. The treating team chooses whether to use a seal.
Worked equipment check. A selected biopsy system allows 10- or 20-mm specimen notches. If the operator identifies only 12 mm from the proposed reference point to a vessel behind the lesion, a 20-mm forward excursion would extend 8 mm beyond that interval. Do not equate notch length with actual forward travel. Check the model’s throw from the identified starting position and have the operator confirm that the complete needle path is safe before firing.
Organ-specific biopsy planning and recovery
1. Percutaneous Transthoracic Lung Biopsy (PTLB)
- Trajectory planning: Choose a safe path under imaging. Where feasible, limit the length in aerated lung and avoid crossing bullae, fissures or major bronchovascular structures. The lesion, access and patient position determine the trajectory.
- Stable post-biopsy positioning: The team may use rapid biopsy-side-down rollover after selected CT-guided biopsies when the patient can be safely turned. A 2026 randomized trial after anterior or lateral approaches found fewer new or enlarging pneumothoraces with the strategy. Continue clinical observation and follow-up imaging according to the recovery plan.
- Pneumothorax: Reassess symptoms, vital signs and imaging. The treating team considers observation, aspiration or chest drainage based on symptoms, size, progression and local resources. Suspected tension pneumothorax requires urgent action.
- Hemoptysis: Report the amount and trajectory of bleeding and assess ventilation and oxygenation. With significant unilateral bleeding, the team may place the bleeding lung down when safe to help protect the opposite lung and activate airway support.
- Systemic air embolism: Gas can enter a pulmonary vein through the needle path or a communication between an airway and vein. Left-heart passage can result in coronary or cerebral embolization. For sudden focal deficits, arrhythmia or severe instability after biopsy, stop the procedure, alert the emergency team, give 100% oxygen when life-threatening gas embolism is suspected, and provide standard resuscitation as needed. The current AHA gas embolism guidance supports level supine or recovery positioning according to the patient's condition. Seek urgent hyperbaric consultation when indicated.
2. Percutaneous or transjugular liver biopsy
For a focal liver lesion, the operator chooses a reachable viable target and reviews the capsule, pleura, adjacent viscera and vessels before choosing an image-guided tract. For diffuse liver disease, the need for histology and the safety of the available routes guide selection. Significant ascites, a difficult percutaneous route or bleeding concerns can favor a transjugular liver biopsy (TJLB). An INR caused by cirrhosis is an incomplete estimate of bleeding risk and a single threshold does not determine the route. Follow the patient-specific procedural and hemostasis plan.
A transjugular approach typically enters the internal jugular vein, passes through the central veins and right atrium into the inferior vena cava, and then selects a hepatic vein. Right hepatic access is common, with an alternate branch when appropriate. The operator uses a dedicated set to sample adjacent parenchyma from the hepatic vein. Avoiding a planned percutaneous capsular puncture can reduce bleeding risk in selected patients. Capsular perforation and hemorrhage remain possible. Monitor the patient and communicate unexpected access-site bleeding, abdominal pain or hemodynamic changes. Hepatic venous pressure measurements may be performed if ordered, with their own equipment and technique.
3. Medical renal biopsy and renal mass biopsy
For medical renal disease, the goal is an adequate sample of renal cortex with glomeruli. With a native kidney, a peripheral lower-pole approach is one common route. Ultrasound often guides the procedure, with another modality used for selected anatomy or access. Plan a route away from the hilum and major vessels. Transplant anatomy requires its own accessible cortical target and patient positioning. Monitor for pain, hematuria, hematoma and changes in perfusion. Coordinate specimens for light microscopy, immunofluorescence and electron microscopy with the renal laboratory.
For a solid renal mass, biopsy can be useful when results will affect management. When biopsy is chosen, the AUA favors multiple cores over FNA for the specified setting. The operator uses ultrasound or CT to target viable tissue and find a path that avoids bowel, large vessels and collecting-system injury where possible. The focal target dictates the route.
Specimen allocation and rapid on-site evaluation
Prepare the requested transport media and containers before sampling. Match each container to the patient, site and test. Communicate the specimen type, timing and special handling to the receiving team.
| Laboratory purpose | Typical preparation or transport |
|---|---|
| Routine histology and many immunostains | Use the laboratory's specified fixative, commonly 10% neutral buffered formalin. |
| Flow cytometry | Keep the designated portion viable in the lab's specified medium, such as RPMI. Keep that portion out of routine formalin and coordinate prompt transfer. Other tissue may be reserved for histology and other studies. |
| Microbiology culture | Collect a separate sterile specimen without routine fixative. Use the specified container and transport conditions, including anaerobic transport if required. |
| Cytology | Prepare smears, needle rinses or cell blocks according to the site protocol. Air-dried and alcohol-fixed preparations support different stains. |
| Medical renal pathology | Use the renal laboratory’s kit and allocation instructions for light microscopy, immunofluorescence and electron microscopy. |
Rapid on-site evaluation (ROSE) gives the procedural team timely feedback on sampling and can help direct additional passes or allocation. An initial impression of adequacy does not guarantee a final diagnosis or sufficient material for ancillary tests. For example, if sampling of a mass is requested for both histology and culture, separate the portions at collection. Use the specified fixative for histology and submit the culture portion in the laboratory’s sterile transport container.
The team plans an image-guided biopsy of a suspected primary retroperitoneal sarcoma and needs tissue architecture for classification. Which description best explains the role of the planned core biopsy?
Core biopsy primarily recovers dispersed cells without architectural relationships.
FNA and core biopsy preserve identical amounts of tissue architecture.
A cytologic aspirate guarantees definitive tumor typing and grading.
A compatible cutting needle can recover tissue with preserved architecture for histology and indicated ancillary tests.
After an anterior CT-guided biopsy of a right lung nodule, a stable patient can be repositioned safely. The team orders rapid biopsy-side-down rollover as part of the recovery protocol. Which action and rationale fit that protocol?
Place the right side down. This strategy can reduce the risk of a new or enlarging pneumothorax in selected patients.
Place the left side down because this is the biopsied side.
Sit the patient upright to vent intrapleural air through the airways.
Use steep head-down positioning to re-expand the lung.
Hepatology needs a parenchymal sample in a patient with diffuse liver disease and significant ascites. The operator determines the percutaneous route is unsuitable because of access and bleeding concerns. Which route fits this need?
Ultrasound-guided percutaneous core biopsy using the tract already judged unsuitable.
Transjugular liver biopsy through a hepatic vein, with a procedural plan and monitoring for bleeding.
Fine-needle aspiration of ascitic fluid for the requested liver parenchymal architecture.
Targeted biopsy of an unrelated hepatic cyst instead of sampling liver parenchyma.
Sections you finish are checked off in the contents.